Surexam

Company Overview

Surexam Biotechnology Co Ltd (SUREXAM) is the pioneer and leader of the personalised medicine industry in China, and the first member of PMC (Personalised Medicine Coalition) from China.

Since its establishment in 2006, SUREXAM dedicated to the individual medical target detection products research and development, production and marketing. Up to now, more than 10 treatments using molecular diagnostic products have been developed and widely implemented in the clinical treatment of tumours, which significantly improved the level of clinical treatment in China.

What attributes do you look for when recruiting graduates?

Surexam seeks dynamic hands-on scientists who are highly motivated to join our efforts in discovery and development of new technologies in the field of personalised medicine. The successful candidates will lead highly productive teams as project managers.